Mounjaro gallbladder symptoms: what to watch for and when to act

What the trial data and SmPC actually say about gallbladder events

The SURMOUNT-1 trial (2,539 adults with obesity, no diabetes, followed for 72 weeks) forms the centrepiece of Mounjaro's weight-management evidence base. Alongside the headline weight-loss results, the safety data recorded gallbladder-related adverse events in a proportion of participants. Cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation) appear in the Mounjaro SmPC as listed adverse reactions, meaning they were identified with sufficient frequency across the trial programme to require formal disclosure. You can read the full adverse-reaction table in the Mounjaro SmPC on the electronic Medicines Compendium (eMC), which is the authoritative UK product document.

There is a plausible biological reason behind this. Rapid weight loss, regardless of method, is a well-established trigger for gallstone formation: when the body breaks down fat quickly, the liver secretes more cholesterol into bile than the gallbladder can efficiently process, and crystals can form. Tirzepatide produces significant and relatively fast reductions in body weight. That speed of change, combined with altered gut-hormone signalling affecting digestion and motility, creates conditions where gallbladder stress is possible for some people. This does not mean gallbladder problems will happen to you (most people on Mounjaro do not experience them) but it does mean they are worth knowing about before you start. A fuller look at Mounjaro's side-effect profile more broadly puts this in context alongside the more common gastrointestinal effects.

The risk is not unique to tirzepatide. Similar signals have been seen with other GLP-1 medicines. What sets Mounjaro apart is the degree of weight loss achieved, which in some respects amplifies the general obesity-medication gallbladder picture.

Symptoms that deserve attention, and the one check anyone can do quickly

Gallbladder pain has a fairly distinctive pattern, which helps. It typically presents as a sharp, cramping or aching pain in the upper-right abdomen, often radiating through to the right shoulder blade or mid-back. The pain commonly arrives within an hour of eating, especially after a fatty meal, because the gallbladder contracts to release bile when fat enters the small intestine. If there is a stone or inflammation in the way, that contraction hurts. Episodes can last between 15 minutes and several hours.

Here is the practical check: after your next meal, press gently with your fingertips just below your right ribcage. Mild tenderness can follow any rich meal, but sharp, reproducible pain at that spot (especially if it radiates toward your shoulder) is worth taking seriously rather than assuming it is ordinary indigestion. That takes under a minute and could prompt you to contact a clinician sooner rather than later.

Other symptoms associated with gallbladder trouble include nausea and vomiting alongside the pain, fever or chills if infection has set in, and yellowing of the skin or whites of the eyes (jaundice), which suggests a stone has moved to block the bile duct. The NHS medicines page for tirzepatide lists the side effects you should be aware of, including gastrointestinal reactions. For a closer look at how gallbladder pain specifically presents on Mounjaro, our guide to gallbladder pain on Mounjaro goes into further detail.

When to get medical help, and what counts as urgent

Not every twinge after eating requires A&E. But some symptoms do, and the distinction matters. Contact your GP or 111 the same day if you experience upper-right abdominal pain that is new, that lasts more than a few hours, or that keeps returning after meals. Do not wait to see whether it resolves on its own over several days.

Call 999 or go to A&E immediately if the pain is severe and does not ease, if you develop a fever above 38°C alongside the abdominal pain, if your skin or eyes turn yellow, or if you notice very dark urine and pale stools, these point to possible bile-duct obstruction or infection of the gallbladder (acute cholecystitis), which are medical emergencies. Tell the treating team that you are taking tirzepatide; it is relevant to how they investigate and manage you.

There is a separate but related concern worth knowing: severe, persistent stomach pain that spreads to the back (particularly if accompanied by vomiting) may indicate pancreatitis rather than a gallbladder problem. The MHRA flagged acute pancreatitis as a known, infrequent but serious risk of GLP-1 medicines in a Drug Safety Update issued in January 2026. Our page on Mounjaro and pancreas symptoms covers this in detail, and recognising pancreatitis symptoms on Mounjaro explains how to tell the two apart when the location of pain overlaps. If in any doubt about which you are experiencing, treat it as urgent.

Any side effect you suspect is linked to Mounjaro can be reported through the MHRA's Yellow Card scheme, which is open to patients as well as healthcare professionals. Reports help the regulator monitor emerging safety signals across the population taking these medicines.

Starting Mounjaro when you have gallbladder history, the prescriber conversation

If you have had gallstones, cholecystitis, or previous gallbladder surgery, that history is part of the clinical assessment before Mounjaro is prescribed. It does not automatically rule you out, but it changes the risk-benefit calculation and may affect how closely you are monitored. A prescriber needs the full picture.

At nume, every consultation is read by a GPhC-registered Independent Prescriber before any prescription is issued. There is no automated approval. If your medical history raises questions about gallbladder risk, our prescribers discuss suitability with you directly. You can also read about tirzepatide and gallbladder risk for more on the clinical background, or visit our Mounjaro overview page for the broader treatment picture. To talk to our team or begin the process, check your eligibility via a free consultation, our prescribers cover side effects, your history and what to watch for as part of that conversation.